What is IVIG?
Intravenous immunoglobulin (IVIG) is a blood product used to treat a variety of medical conditions. IVIG is often used as a preventative treatment for patients with conditions affecting their immune system. It is also sometimes needed as an urgent treatment for patients facing immediate, life-threatening illnesses.
Why is there an IVIG shortage, and how long is it expected to last?
The root cause of the shortage is not known. This is a nationwide shortage, many hospitals are experiencing the same problem and the end to the shortage is unknown.
Who receives IVIG treatments?
MAH patients who receive care through the following departments may have their care impacted:
- Infectious Disease
Is the IVIG shortage affecting MAH patients?
Not yet. Currently we have sufficient supply to treat our current active patients. However it is possible there may be temporary interruptions in IVIG treatments for some patients in order to ensure we have enough IVIG for patients who are facing life-threatening illnesses.
What is MAH doing to help patients during the shortage?
We are monitoring the current supply and planning both short-term and long term solutions. A multidisciplinary task force has been working on optimizing our supply and ensuring that there are clear guidelines and policy for distributing the supply that we have now and in the future.
Will this shortage affect my treatment plan?
The shortage may affect patients who receive routine IVIG treatments, but MAH care teams are doing everything possible to identify alternative treatment plans. We are also working to obtain more IVIG from manufacturers as soon as it is available.
Are there any alternatives patients should consider?
Patients should speak to a member of their care team to determine if other treatment options should be pursued during the shortage.
Please contact your provider's office with any questions.